Full Name | Jacqulynn Salem |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 200 Levi Ln, Adams, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609385285 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 2161 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jacqulynn Salem, 200 Levi Ln, Adams, NE 68301-8830 Ph: () - | Jacqulynn Salem, 200 Levi Ln, Adams, NE 68301-8830 Ph: (402) 988-7115 |
News Archive
Janssen Therapeutics, Division of Janssen Products, LP, presented today 96-week findings from two pivotal Phase 3 clinical trials, known as ECHO and THRIVE, comparing the efficacy, safety and virology profile of its non-nucleoside reverse transcriptase inhibitor EDURANT tablets versus efavirenz (EFV) in antiretroviral treatment-naive, HIV-1-infected adults.
Rep. Lois Capps (D-Calif.) "called climate change a bigger public health threat than AIDS, malaria and pandemic flu" before a vote on Wednesday on a bill aimed at thwarting Environmental Protection Agency climate regulations, The Hill's "E2-Wire" blog reports.
Older women who have lost more than two inches in height face an increased risk of breaking bones and dying, according to a new study published in the January issue of the Journal of Bone and Mineral Research and funded by the National Institutes of Health.
Inhaled insulin, taken before meals, can improve blood glucose control for people with type 2 diabetes who have not had good results with short-acting injected insulin that is taken in addition to the baseline insulin administered throughout the day and night, according to a new review of the body of published research.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
› Verified 9 days ago
Sarah Elizabeth Byrne, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Levi Ln, Adams, NE 68301 Phone: 402-988-7115 |